Centene Corp to Announce Q4 2025 Financial Results
Written by Emily J. Thompson, Senior Investment Analyst
Updated: 15 Jan 26
Source: Newsfilter
Centene Corp (CNC) has seen a price increase of 3.01% as it reaches a 20-day high, reflecting positive market conditions.
The company is set to release its fourth quarter and year-end financial results for 2025 on February 6, 2026, at 6:00 a.m. ET, followed by a conference call at 9:00 a.m. ET. This announcement highlights Centene's ongoing commitment to healthcare excellence and is expected to provide investors with valuable insights into its financial performance.
This upcoming earnings report could further enhance investor confidence and support the stock's upward momentum, especially in light of the broader market gains.
Analyst Views on CNC
Wall Street analysts forecast CNC stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for CNC is 43.07 USD with a low forecast of 32.00 USD and a high forecast of 59.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
15 Analyst Rating
5 Buy
8 Hold
2 Sell
Hold
Current: 41.900
Low
32.00
Averages
43.07
High
59.00
Current: 41.900
Low
32.00
Averages
43.07
High
59.00
About CNC
Centene Corporation is a healthcare company. The Company provides fully integrated services to government-sponsored and commercial healthcare programs, focusing on under-insured and uninsured individuals. Its segments include Medicaid, Medicare, Commercial and Other. Specifically, the Medicaid segment includes the Temporary Assistance for Needy Families (TANF) program, Medicaid Expansion programs, the Aged, Blind or Disabled (ABD) program, the Children's Health Insurance Program (CHIP), Long-Term Services and Supports (LTSS), Foster Care, Medicare-Medicaid Plans (MMP), which cover beneficiaries who are dually eligible for Medicaid and Medicare and other state-based programs. The Medicare segment includes Medicare Advantage, Medicare Supplement, Dual Eligible Special Needs Plans and Medicare Prescription Drug Plans. The Commercial segment includes the Health Insurance Marketplace product along with individual, small group, and large group commercial health insurance products.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
